Form 4 for HCA HCA Healthcare
Accepted 2023-02-01 00:00:00 ET · period of report 2023-01-30 · accession 0001209191-23-006045 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-01 | 2023-01-31 | HCA | Wyatt Christopher F. | SVP, Ctrl | G - Gift | $0.00 | -379 | 37.3K | -1% | $0 |
| D | 2023-02-01 | 2023-02-01 | HCA | Wyatt Christopher F. | SVP, Ctrl | S - Sale+OE | $253.30 | -4,900 | 32.4K | -13% | -$1.24M |
| D | 2023-02-01 | 2023-01-30 | HCA | Wyatt Christopher F. | SVP, Ctrl | M - OptEx | $81.96 | +12.0K | 44.2K | +37% | +$983.5K |
| D | 2023-02-01 | 2023-01-30 | HCA | Wyatt Christopher F. | SVP, Ctrl | F - Tax | $253.30 | -6,513 | 37.7K | -15% | -$1.65M |
| D | 2023-02-01 | 2023-01-30 | HCA | Wyatt Christopher F. | SVP, Ctrl | M - OptEx | $0.00 | -12.0K | 2,680 | -82% | $0 |
| D | 2023-02-01 | 2023-01-30 | HCA | Wyatt Christopher F. | SVP, Ctrl | A - Grant | $0.00 | +5,052 | 5,052 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-31 | G | D | 379 | $0.00 | 37,292 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-01 | S | D | 4,900 | $253.30 | 32,392 | D | — | — | |
| 3 | Common | Common Stock | 2023-01-30 | M | A | 12,000 | $81.96 | 44,184 | D | — | — | |
| 4 | Common | Common Stock | 2023-01-30 | F | D | 6,513 | $253.30 | 37,671 | D | — | — | |
| 5 | Derivative | Stock Appreciation Right | 2023-01-30 | M | D | 12,000 | $0.00 | 2,680 | D | $81.96 · — to 2027-02-01 | 12,000 Common Stock | (F1) The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. |
| 6 | Derivative | Stock Appreciation Right | 2023-01-30 | A | A | 5,052 | $0.00 | 5,052 | D | $253.30 · 2024-01-30 to 2033-01-30 | 5,052 Common Stock | (F2) The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024. |